research papers
Here, new crystal structures are presented of the isolated membrane-proximal D1 and distal D2 domains of protein tyrosine phosphatase epsilon (PTP), a protein tyrosine phosphatase that has been shown to play a positive role in the survival of human breast cancer cells. A triple mutant of the PTP D2 domain (A455N/V457Y/E597D) was also constructed to reconstitute the residues of the PTP D1 catalytic domain that are important for phosphatase activity, resulting in only a slight increase in the phosphatase activity compared with the native D2 protein. The structures reported here are of sufficient resolution for structure-based drug design, and a microarray-based assay for high-throughput screening to identify small-molecule inhibitors of the PTP D1 domain is also described.
Keywords: microarray assay; protein tyrosine phosphatase; PTP; receptor-like protein tyrosine phosphatase; RPTP; structure-based drug design.
Supporting information
Portable Document Format (PDF) file https://doi.org/10.1107/S2059798318011919/ni5003sup1.pdf |
PDB references: PTPɛ D1 domain, 6d4d; PTPɛ D2 domain, 6d3f; PTPɛ D2 domain, A455N/V457Y/E597D mutant, 6d4f